Allen Jim L. 4
4 · BioCardia, Inc. · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
BioCardia (BCDA) Director Jim L. Allen Receives 8,000-Share Award
What Happened
- Jim L. Allen, a director of BioCardia, was granted a derivative award for 8,000 shares on 2026-07-06. The filing lists an acquisition price of $0.00 (total reported cash = $0). The award is reported as a grant/award (transaction code A), not a sale or open-market purchase.
Key Details
- Transaction date: 2026-07-06; Filing date: 2026-07-07 (timely).
- Award: 8,000 derivative shares; reported acquisition price $0.00.
- Shares owned after transaction: not provided in the supplied data.
- Footnote: 100% of the shares vest and become exercisable on the one-year anniversary of the grant (i.e., 2027-07-06), contingent on Allen continuing as a service provider through that date.
- No 10b5-1 plan, tax-withholding, or late-filing flags noted in the provided information.
Context
- This is a compensation-style award that vests in one year; there is no immediate cash outlay or sale of shares. Derivative awards like this are commonly used for director compensation and do not by themselves indicate buying or selling intentions in the open market.
Insider Transaction Report
Form 4
BioCardia, Inc.BCDA
Allen Jim L.
Director
Transactions
- Award
Stock Option (right to buy)
[F1]2026-07-06+8,000→ 23,313 totalExercise: $1.20Exp: 2036-07-06→ Common stock (8,000 underlying)
Footnotes (1)
- [F1]One hundred percent of the shares are subject to the option vesting and becoming exercisable on the one-year anniversary of the date of grant, subject to the Reporting Person continuing as a service provider through such date.
Signature
/s/ David McClung, by power of attorney|2026-07-07